Soriatane

Soriatane is a brand name of acitretin, approved by the FDA in the following formulation(s):

SORIATANE (acitretin - capsule; oral)

• 
  Manufacturer: STIEFEL LABS INC
  
  Approval date: October 28, 1996
  
  Strength(s): 10MG, 25MG ^[RLD]


• 
  Manufacturer: STIEFEL LABS INC
  
  Approval date: August 6, 2009
  
  Strength(s): 17.5MG, 22.5MG
  

Has a generic version of Soriatane been approved?

No. There is currently no therapeutically equivalent version of Soriatane available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Soriatane. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Soriatane.

See also...

• Soriatane Consumer Information (Wolters Kluwer)
• Soriatane Consumer Information (Cerner Multum)
• Soriatane Advanced Consumer Information (Micromedex)
• Soriatane AHFS DI Monographs (ASHP)
• Acitretin Consumer Information (Wolters Kluwer)
• Acitretin with Moisturizer Consumer Information (Wolters Kluwer)
• Acitretin Consumer Information (Cerner Multum)
• Acitretin Advanced Consumer Information (Micromedex)
• Acitretin AHFS DI Monographs (ASHP)